Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
EHC logo EHC
Upturn stock ratingUpturn stock rating
EHC logo

Encompass Health Corp (EHC)

Upturn stock ratingUpturn stock rating
$93.06
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/14/2025: EHC (4-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Above Average Performance

These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.

AI Based Fundamental Rating

ratingratingratingratingrating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

Analysis of Past Performance

Type Stock
Historic Profit 63.5%
Avg. Invested days 125
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 5.0
Stock Returns Performance Upturn Returns Performance 3.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/14/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 9.38B USD
Price to earnings Ratio 21.9
1Y Target Price 116.75
Price to earnings Ratio 21.9
1Y Target Price 116.75
Volume (30-day avg) 603650
Beta 0.78
52 Weeks Range 69.21 - 104.36
Updated Date 01/14/2025
52 Weeks Range 69.21 - 104.36
Updated Date 01/14/2025
Dividends yield (FY) 0.73%
Basic EPS (TTM) 4.25

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 8.1%
Operating Margin (TTM) 15.48%

Management Effectiveness

Return on Assets (TTM) 8.38%
Return on Equity (TTM) 22.92%

Valuation

Trailing PE 21.9
Forward PE 19.34
Enterprise Value 11977077977
Price to Sales(TTM) 1.8
Enterprise Value 11977077977
Price to Sales(TTM) 1.8
Enterprise Value to Revenue 2.3
Enterprise Value to EBITDA 10.47
Shares Outstanding 100750000
Shares Floating 99290693
Shares Outstanding 100750000
Shares Floating 99290693
Percent Insiders 1.31
Percent Institutions 98.56

AI Summary

Encompass Health Corp. (NYSE: EHC): A Deep Dive

Company Profile

History and Background:

  • Founded in 1996 as HealthSouth Corporation, the company initially focused on inpatient rehabilitation services.
  • In 2019, the company rebranded itself as Encompass Health and expanded into home health and hospice services.
  • Today, Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the U.S., with over 135 hospitals and 250 home health locations.

Core Business Areas:

  • Inpatient Rehabilitation: Encompass Health provides inpatient rehabilitation services to patients recovering from strokes, brain injuries, spinal cord injuries, amputations, and other debilitating conditions.
  • Home Health: Encompass Health provides home-based skilled nursing, physical therapy, occupational therapy, and speech therapy to patients recovering from illness or injury.
  • Hospice: Encompass Health offers end-of-life care and support to patients and their families.

Leadership Team and Corporate Structure:

Top Products and Market Share:

  • Inpatient Rehabilitation: Encompass Health holds the largest market share in the U.S. inpatient rehabilitation market, controlling approximately 33%.
  • Home Health: Encompass Health is the fourth largest home health provider in the U.S. with a market share of approximately 4%.
  • Hospice: Encompass Health is the sixth largest hospice provider in the U.S. with a market share of approximately 4%.
  • Competitive Comparison: Encompass Health stands out in the industry for its diversified service offerings, which allows them to care for patients across the entire continuum of post-acute care.

Total Addressable Market

  • The U.S. post-acute care market is estimated to be worth $170 billion, encompassing inpatient rehabilitation, home health, and hospice services.
  • This market is expected to grow at a rate of 5% annually, driven by an aging population and rising prevalence of chronic diseases.

Financial Performance

  • Revenue: Q3 2023 revenue was $1.90 billion, representing a year-over-year increase of 4.6%.

  • Net Income: Q3 2023 net income was $137.2 million, compared to $139.6 million in Q3 2022.

  • Profit Margins: Gross profit margin in Q3 2023 was 15.8% and operating profit margin was 11.5%.

  • Earnings Per Share: Q3 2023 EPS was $1.03 compared to $1.01 in Q3 2022.

  • Financial Performance Comparison:

    • Revenue has grown steadily over the past five years.
    • Profit margins have remained stable.
    • EPS has also grown steadily.
  • Cash Flow and Balance Sheet: Encompass Health has a healthy cash flow and balance sheet. The company has a low debt-to-equity ratio and is generating positive free cash flow.

Dividends and Shareholder Returns:

  • Dividend History: Encompass Health has a history of paying dividends since 2018.
    • Current dividend yield is approximately 1.4%.
    • Payout ratio is approximately 30%.
  • Shareholder Returns: Over the past year, Encompass Health stock has returned 18.2%.
    • Over the past five years, Encompass Health stock has returned 175.1%.

Growth Trajectory

  • Historical Growth: Encompass Health has experienced strong historical growth.
    • Revenue has grown at a compound annual growth rate of 10% over the past five years.
    • EPS has grown at a compound annual growth rate of 15% over the past five years.
  • Future Growth Projections: Encompass Health expects to continue to grow in the future.
    • The company projects revenue growth of 5-7% in 2023.
    • The company also expects to expand its margins and grow its EPS.
  • Recent Growth Initiatives: Encompass Health is making several investments to drive future growth.
    • The company is expanding its inpatient rehabilitation network.
    • The company is investing in technology to improve patient care and efficiency.

Market Dynamics

  • Industry Trends: The post-acute care industry is expected to continue to grow in the future. This growth will be driven by an aging population and rising prevalence of chronic diseases.
  • Demand-Supply: The supply of post-acute care services is expected to meet demand in the coming years.
  • Technological Advancements: Technology is playing an increasing role in the post-acute care industry. Encompass Health is investing in technology to improve patient care and efficiency.

Competitors

  • Major competitors:

    • Kindred Healthcare (KND) - Market Share: 17%
    • Select Medical (SEM) - Market Share: 14%
    • Amedisys (AMED) - Market Share: 5%
  • Competitive Advantages: Encompass Health has several competitive advantages, including:

    • Largest market share
    • Diversified service offerings
    • Strong financial position
    • Investment in technology

Potential Challenges and Opportunities

Key Challenges:

  • Supply Chain Issues: Encompass Health is facing some supply chain issues, which could impact the cost of care.
  • Technological Changes: The post-acute care industry is constantly evolving, and Encompass Health needs to keep up with the latest technological advancements.
  • Competitive Pressures: Encompass Health faces competition from other large post-acute care providers.

Opportunities:

  • **New Market

About NVIDIA Corporation

Exchange NYSE
Headquaters Birmingham, AL, United States
IPO Launch date 1986-09-30
CEO, President & Director Mr. Mark J. Tarr
Sector Healthcare
Industry Medical Care Facilities
Full time employees 27481
Full time employees 27481

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​